Dopamine and Huntington's disease.

Dopamine and Huntington's disease.

Item
http://www.wikidata.org/entity/Q38379277
The Allure of High-Risk Rewards in Huntington's disease.Huntingtin Is Required for Neural But Not Cardiac/Pancreatic Progenitor Differentiation of Mouse Embryonic Stem Cells In vitro.Striatal Vulnerability in Huntington's Disease: Neuroprotection Versus Neurotoxicity.Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.COMT Val158Met Polymorphism Modulates Huntington's Disease Progression.Advancing pharmacotherapy for treating Huntington's disease: a review of the existing literature.Pridopidine for the treatment of Huntington's disease.Antipsychotic drugs in Huntington's disease.Investigational agents for the management of Huntington's disease.Disease-modifying effects of ganglioside GM1 in Huntington's disease models.Mechanisms of multiple neurotransmitters in the effects of Lycopene on brain injury induced by Hyperlipidemia.Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's Disease.Therapy development in Huntington disease: From current strategies to emerging opportunities.
P2860

Dopamine and Huntington's disease.

Item
http://www.wikidata.org/entity/Q38379277
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Dopamine and Huntington's disease.
@en
type
label
Dopamine and Huntington's disease.
@en
prefLabel
Dopamine and Huntington's disease.
@en
P1433
P1476
P2093
P2507
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Dopamine and Huntington's disease
@en
P2093
P2507
P2860
P304
P31
P356
10.1586/14737175.2015.1025383
P433
P478
P50
P577
P5875
P698
P921